Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

August 2021 | 46 pages | ID: G63D3D7D18FEN
GlobalData

Abstracts

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, that manufactures active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Ibuprofen, Paracetamol, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With offices in India, the US, the UK and Colombia, the company offers products and solutions to in over 75 countries across the world. Granules also provides contract research and manufacturing services. Its key clients include leading generic and branded pharmaceutical companies. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

Jul 27,2021: Granules Un-Audited Financial Results For The Quarter Ended June 30,2021
Jul 21,2021: Granules Pharmaceuticals clears US FDA audit
Jun 27,2021: Granules Pharmaceuticals: Completion of US FDA audit at GPI facility
Jan 28,2021: Granules India Announces Financial Results For The Quarter Ended December 30, 2020
Jan 28,2021: Granules India Declared third interim dividend for the financial year 2020-21

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Granules India Ltd - Key Facts
Granules India Ltd - Key Employees
Granules India Ltd - Key Employee Biographies
Granules India Ltd - Major Products and Services
Granules India Ltd - History
Granules India Ltd - Company Statement
Granules India Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Granules India Ltd - Business Description
Business Segment: API
Overview
Performance
Business Segment: FD
Overview
Performance
Business Segment: PFI
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
R&D Overview
Granules India Ltd - Corporate Strategy
Granules India Ltd - SWOT Analysis
SWOT Analysis - Overview
Granules India Ltd - Strengths
Granules India Ltd - Weaknesses
Granules India Ltd - Opportunities
Granules India Ltd - Threats
Granules India Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Granules India Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 27, 2021: Granules Un-Audited Financial Results For The Quarter Ended June 30,2021
Jul 21, 2021: Granules Pharmaceuticals clears US FDA audit
Jun 27, 2021: Granules Pharmaceuticals: Completion of US FDA audit at GPI facility
Jan 28, 2021: Granules India Announces Financial Results For The Quarter Ended December 30, 2020
May 28, 2020: Granules India : Clarification on the presence of NDMA in the Company’s Products
Apr 07, 2020: Granules India's Visakhapatnam facility received EU GMP approval
Feb 15, 2020: Granules India: US FDA completes inspection at Granules India’s Hyderabad facility

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Granules India Ltd, Key Facts
Granules India Ltd, Key Employees
Granules India Ltd, Key Employee Biographies
Granules India Ltd, Major Products and Services
Granules India Ltd, History
Granules India Ltd, Subsidiaries
Granules India Ltd, Key Competitors
Granules India Ltd, Ratios based on current share price
Granules India Ltd, Annual Ratios
Granules India Ltd, Annual Ratios (Cont...1)
Granules India Ltd, Annual Ratios (Cont...2)
Granules India Ltd, Interim Ratios
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Granules India Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Granules India Ltd, Performance Chart (2017 - 2021)
Granules India Ltd, Ratio Charts
Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021